The 2018 event will showcase invited presentations, abstracts, small group sessions and a lively scientific interchange on anal HPV infection, anal squamous intraepithelial lesions and anal cancer.

Who attends the IANS Scientific Meeting?
Scientists, researchers, physicians and advanced practice clinicians who are involved in anal HPV-associated and related diseases.  This meeting highlights cutting edge research and clinical care for populations most impacted by HPV including MSM, men and women with HIV disease and women with HPV related disease. Attendees will include professionals from multiple fields, including molecular biology, epidemiology, pathology and direct clinical care providers such as family practice, internal medicine and infectious disease, gastroenterology, general surgery, colorectal surgery and gynecology.

The educational learning objectives for this meeting:

  1. Understand approaches to identifying HSIL
  2. Learn the latest information on populations at risk for HSIL and anal cancer, and implement optimal testing strategies for screening,
  3. Learn the latest information on treatment of HSIL and post-treatment follow-up of lesions,
  4. Understand new approaches to treatment of anal cancer
  5. Understand the impact of screening and treatment of anal HSIL and cancer on patients,
  6. Understand the latest concepts of molecular pathogenesis of anal HSIL and cancer. 

The only global conference on anal cancer and other 
anal HPV-associated conditions.

Keynote speaker:

Dr. Eliav Barr

Senior Vice President, Infectious Diseases and Vaccines Clinical Development 
Merck Research Laboratories, United States

The impact of HPV vaccination: global, local, men, women 

*Image has been provided byTourisme Montréal, Stéphan Poulin.  Publishing rights have been granted to IANS.

International Anal Neoplasia Society

PO Box 1543
Leesburg, Virginia 20177
Powered by Wild Apricot Membership Software